A new study suggests a simple blood test -- administered before CAR-T cell treatment is initiated -- may identify which patients are predisposed to developing neurotoxic side effects in the days and weeks after CAR-T cell therapy.
from Top Health News -- ScienceDaily https://ift.tt/kHjcywh
Post a Comment